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1. Introduction 
Ulcerative colitis (UC), together with Crohn’s disease (CD), collectively called inflammatory 
bowel disease (IBD), is a chronic, spontaneously remitting, and relapsing disorder of large 
intestine, characterized by abdominal pain and diarrhea. UC differs dramatically from CD 
with the respects of disease distribution, morphology, and histopathology; meantime, they 
share a lot of inflammatory similarities, such as epithelial barrier dysfunction. UC may 
result in significant morbidity and mortality, with compromised quality of life and life 
expectancy. While there is no cure for UC, the last two decades have seen tremendous 
advances in our understanding of the pathophysiology of this intestinal inflammation. Even 
though the precise etiology of IBD remains elusive, it is accepted that UC arises from 
abnormal host–microbe interactions, including qualitative and quantitative changes in the 
composition of the microbiota, host genetic susceptibility, barrier function, as well as innate 
and adaptive immunity.  
Intracellular signaling cascades mediated by protein kinases are the main route of 
communication between the plasma membrane and regulatory targets in various 
intracellular compartments. The signaling pathway mediated by protein kinase plays an 
important role in transducing signals from diverse extra-cellular stimuli (including growth 
factors, cytokines and environmental stresses) to the nucleus in order to affect a wide range 
of cellular processes, such as proliferation, differentiation, development and apoptosis, and 
more importantly, also involved in intestinal inflammation.  
In this chapter, we are going to focus on the involvement protein kinases in the pathogenesis 
of UC, try to shed some light on the clues of intervention of UC. 
2. Genetic factor  
Population-based studies provided compelling evidence that genetic susceptibility plays an 
essential role in the pathogenesis of UC, evidence including an 8- to 10-fold greater risk 
among relatives of UC and greater rates of concordance between twins in UC patients 
(15.4% in monozygotic vs 3.9% in dizygotic twins) (Cho & Brant, 2011). Some of genes 
encoding protein kinase like ERK1 (Hugot et al. 1996) and p38ǂ (Hampe et al. 1999) are 
located in major IBD susceptibility regions on chromosome 16 and 6. Recently, substantial 
advances have been achieved in defining the genetic architecture of UC since the genome-
wide association study (GWAS) analysis heralded a new era of complex disease gene 
discovery with notable success in CD initially and latterly also in UC. To date, over 60 
published IBD susceptibility loci have been discovered and replicated, of which 
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Fig. 1. Pathogenesis of UC. Many different factors, such as genetic factors, environmental 
factors, and intestinal non-pathogenic or pathogenic bacteria can damage the mucus, 
epithelium, or the tight junction, to initiate the inappropriate regulation or deregulation of 
the immune response, leading to the secretion of pro-inflammatory cytokines, decrease in 
epithelial barrier function and initiation of the inflammation-related signaling pathways. 
IEC: Intestinal epithelial cell; APC: Antigen presenting cell; TJ: Tightjunction. This model 
adapted from the model presented previously (Yan 2008) 
approximately one third are associated with both UC and CD, although 21 are specific to UC 
and 23 to CD (Thompson & Lees, 2011). Importantly, most of the genes have been linked to 
defects in innate and adaptive immunity and epithelial barrier function. Notably, 
extracellular matrix gene 1 (ECM1) (Festen et al. 2010), E-cadherin gene (CDH1), Hepatocyte 
nuclear factor 4 alpha gene (HNF4a), and laminin B1 (Barrett et al. 2009) are genes 
implicated in mucosal barrier function, conferring risk of UC; ECM1 interacts with the 
basement membrane, inhibits matrix metalloproteinase 9 (MMP9), and strongly activate 
NFκB (Chan et al. 2007; Matsuda et al. 2003). The Wnt/beta-catenin signal transduction 
pathway has been shown to influence ECM1 expression (Kenny et al. 2005). E-cadherin is 
the first genetic correlation between colorectal cancer and UC, Chimeric mice with impaired 
E-cadherin function due to expression of dominant–negative N-cadherin developed colitis 
despite possessing an intact immune system (Hermiston & Gordon 1995a, 1995b). Notably, 
all of these 4 genes are regulated or related to protein kinases, for example, HNF4alpha-
DNA binding activity is dependent on its phosphorylation by protein kinase A (PKA) 
(Viollet  et al. 1997), while its transcription activity was dependent on AMP-activated 
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Fig. 2. Susceptible loci for UC. This model is adapted from the model presented previously 
(Thompson & Lees 2001) 
3. Microbiota and immune responses 
The human gastrointestinal (GI) tract contains as many as 1014 individual bacteria, 
comprising over 500 different species. These commensal bacteria serves as a primary barrier 
between the intestinal epithelial cells and the external environment, which is critical to the 
healthy host, as it modulates intestinal development, maintains a healthy intestinal pH, 
promotes immune homeostasis, and enhances metabolism of drugs, hormones and 
carcinogens. Evidence from immunologic, microbiologic, and genetic studies implicates 
abnormal host-microbial interactions in the pathogenesis of UC. But the mechanisms 
underlying the involvement of microbiota are elusive, and the effects of microbiota are due 
to their interaction with other factors, such as immunologic factors, genetic factor or 
epithelial junction proteins. The postulated mechanisms (Packey & Sartor, 2008) are as 
followed with little modification: (a) Pathogenic bacteria. A traditional pathogen or 
functional alterations in commensal bacteria, including enhanced epithelial adherence, 
invasion, and resistance to killing by phagocytes or acquisition of virulence factors, can 
result in increased stimulation of innate and adaptive immune responses. (b) Abnormal 
microbial composition. Decreased concentrations of bacteria that produce butyrate and 
other short-chain fatty acids (SCFA) compromise epithelial barrier integrity. (c) Defective 
host containment of commensal bacteria. Increased mucosal permeability can result in 
overwhelming exposure of bacterial toll like receptor (TLR) ligands and antigens that 
activate pathogenic innate and T cell immune responses. (d) Defective host 
immunoregulation. Antigen-presenting cells and epithelial cells overproduce cytokines due 
to ineffective downregulation, which results in TH1 and TH17 differentiation and 
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inflammation. Dysfunction of regulatory T cells (T-reg) leads to decreased secretion of IL-10 
and TGF-ǃ, and loss of immunological tolerance to microbial antigens (an overly aggressive 
T cell response).  
UC is commonly regarded as the consequences of an enhanced inflammatory response or 
the lack of a down regulatory response to bacteria abnormality. The dysregulated immune 
response involving the innate (for example, TLR, DC, etc) and the adaptive immune system 
(e.g. effector T-cells, regulatory T-cells, eosinophils, neutrophils, etc) may follow or precede 
the macroscopic lesions. Crohn’s disease is a predominantly TH1- and TH17-mediated 
process, while the immunopathogenesis of UC has been a more difficult disease to ascertain, 
neither IFN-Ǆ (a major Th1 cytokine) nor IL-4 (the major Th2 cytokines) was increased (Fuss 
et al, 2008). In fact, IL-4 production was found to be decreased in cells extracted from UC 
tissue and only the fact that an additional Th2 cytokine IL-5 secretion by these cells was 
somewhat increased hinted that the disease may have a Th2 character. Further, enhanced 
level of IL-13 was noticed in lamina propria from UC specimens, whereas those from 
Crohn’s disease specimens were producing IFN-Ǆ (Fuss et al, 1996). Fuss (Fuss et al, 2004) 
found that antigen-presenting cells bearing a CD1d construct (and thus expressing CD1d on 
its surface, which presents lipid rather than protein antigens to T cells.) could only induce 
lamina propria mononuclear cells from UC patients but not that of Crohn’s disease to 
produce IL-13. Thereby, the cytokine secretion profile seen in UC was produced from a non-
classical CD1 dependent NK T cell whereas the cytokines produced in Crohn’s disease were 
from that of an activated classical Th1 CD4 + T cell. In addition, Lamina propria cells 
enriched for NK T cells from the patients could be shown to be cytotoxic for epithelial cells 
and such cytotoxicity was further enhanced by IL-13. Antigens in the mucosal microflora 
activate NK T cells because of barrier dysfunction that, in turn, cause cytolysis of epithelial 
cells and the characteristic ulcerations associated with the disease. As suggested, 
enhancement of cytolytic activity was observed in vitro in the presence of IL-13. Further, IL-
13 was shown to have direct effects on activation of cytokine transcription. These studies 
demonstrated that TGF-ǃ transcription was dependent upon IL-13. In short, UC is 
associated with an atypical TH2 response mediated by a distinct subset of NK T cells that 
produce IL-13 and are cytotoxic for epithelial cells (Fuss et al. 2008). Further, UC is 
characterized by the presence of various types of autoantibodies against goblet cells and the 
isoforms 1 and 5 of human tropomyosin.  
The intestinal mucosa must rapidly recognize detrimental pathogenic threats to the lumen 
to initiate controlled immune responses but maintain hyporesponsiveness to omnipresent 
harmless commensals. Pattern recognition receptors (PRRs) may play an essential role in 
allowing innate immune cells to discriminate between ‘‘self’’ and microbial ‘‘non-self’’ based 
on the recognition of broadly conserved molecular patterns. Toll-like receptors (TLRs), a 
class of transmembrane PRRs, play a key role in microbial recognition, induction of 
antimicrobial genes, and the control of adaptive immune responses. Individual TLRs 
differentially activate distinct signaling events via diverse cofactors and adaptors. To date, 
at least five different adaptor proteins have been identified in humans: MyD88, Mal/TIRAP, 
TRIF/TICAM-1, TRAM/Tirp/TICAM-2, and SARM (O’Neill et al. 2003). The first identified 
so-called ‘‘classical’’ pathway (Cario 2005) involves recruitment of the adaptor molecule 
MyD88, activation of the serine/threonine kinases of the interleukin 1 receptor associated 
kinase (IRAK) family, subsequently leading to degradation of inhibitor kB (IkB) and 
translocation of nuclear factor kB (NFkB) to the nucleus, then result in activation of specific 
transcription factors, including NFkB, AP-1, Elk-1, CREB, STATs, and the subsequent 
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transcriptional activation of genes encoding pro- and anti-inflammatory cytokines and 
chemokines as well as induction of costimulatory molecules. All of these various 
downstream effects are critically involved in the control of pathogen elimination, 
commensal homeostasis, and linkage to the adaptive immunity. Signaling through different 
TLRs can result in considerable qualitative differences in TH dependent immune responses 
by differential modulation of MAPKs and the transcription factor c-FOS (Agrawal et al. 
2003). So TLR signalling protects intestinal epithelial barrier and maintains tolerance, but 
aberrant TLR signalling may stimulate diverse inflammatory responses leading to UC.  
 
 
Fig. 3. Proposed mechanisms by which bacteria and fungi induce chronic immune-mediated 
inflammation and injury of the intestines. This model adapted from the model presented in 
the work by Dr Sartor (Packey & Sartor 2008) (a) Pathogenic bacteria. (b) Abnormal 
microbial composition. (c) Defective host containment of commensal bacteria. (d) Defective 
host immunoregulation 
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TLR comprise a family of (so far) 11 type-I transmembrane receptors. Different pathogen 
associated molecular patterns selectively activate different TLRs: (Lipoptroteins) TLR1, 2 
and 6; (dsRNA) TLR3; (LPS) TLR4; (Flagellin) TLR5; (ssRNA) TLR7 and 8; (CpG DNA) 
TLR9. These signals all converge on a single pathway via myeloid differentiation primary 
response protein MyD88, which activates NFκB. the NFκB pathway was thought to have 
predominantly pro inflammatory activities and NFκB is activated in the tissues of UC 
patients and its inhibition can attenuate experimental colitis (Neurath et al 1996).  
In intestine, tolerance is an essential mucosal defence mechanism maintaining 
hyporesponsiveness to harmless lumenal commensals and their products. Several molecular 
immune mechanisms that ensure tolerance via TLRs in intestinal epithelial cells (IEC) have 
recently been described, for example, low expression of TLRs at resting conditions in IEC 
can maintain hyporesponsiveness to microbiota; high expression levels of the downstream 
signaling suppressor Tollip which inhibits IRAK activation (Otte et al. 2004), ligand induced 
activation of peroxisome proliferator activated receptor c (PPARc) which uncouples NFkB 
dependent target genes in a negative feedback loop (Dubuquoy et al. 2003. Kelly et al. 2004), 
and external regulators which may suppress TLR mediated signalling pathways. 
Commensal bacteria may assist the host in maintaining mucosal homeostasis by 
suppressing inflammatory responses and inhibiting specific intracellular signal transduction 
pathways (Neish et al. 2000), uncoupling NFkB dependent target genes in a negative 
feedback loop (Dubuquoy et al. 2003) which may lead to attenuation of colonic 
inflammation (Kelly et al. 2004). 
In addition, NF-κB is normally grouped into one of the pro-inflammatory mediators, a 
protective role for epithelial NF-κB signaling by either bacteria, IL-1, or TNF stimulation of 
TLRs, or cytokine receptors is demonstrated by conditional ablation of NEMO (IκB kinase) 
in intestinal epithelial cells causing spontaneous severe colitis (Nenci et al. 2007). Blockade 
of epithelial NF-κB signaling led to increased bacterial translocation across the injured 
epithelium, similar to toll like receptor (TLR)4-deficient mice treated with dextran sulphate 
sodium (DSS) (Fukata et al. 2006). 
4. Barrier dysfunction 
Generally, intestinal barrier function consists of different level of defense lines, the mucus 
layer, commensal microbiota, epithelial cells themselves, the junction between lateral 
epithelial cells, innate and adaptive immune systems and enteric nerve system. Any stresses 
which interfere with any level of this defense lines could potentially lead to intestinal barrier 
dysfunction and result in intestinal inflammation.  
Epithelial cells form a continuous, polarized monolayer that is linked together by a series of 
dynamic junctional complexes. Except function as a physical barrier, epithelial cells 
maintain a mucosal defense system through the expression of a wide range of PRRs, such as 
TLRs. These PRRs form the backbone of the innate immune system through the rapid 
response and recognition of the unique and conserved microbial components, (Medzhitov & 
Janeway. 2002; Akira et al. 2006). Tight junctions are composed of transmembrane proteins 
(claudins, occludins, and junctional adhesion molecule [JAM]), peripheral membrane or 
scaffolding proteins (zonula occludens [ZO]), and intracellular regulatory molecules that 
include kinases and actin. An anatomically and immunologically compromised intestinal 
epithelial barrier allows direct contact of the intestinal mucosa with the luminal bacteria and 
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plays a crucial role in the development and maintenance of UC by initiating chronic 
inflammatory responses, although it is unclear whether this is a primary pathogenic process 
or secondary to inflammation. Since the contribution of genetic factors, microbiota and 
immune responses to the pathogenesis to UC, we high light the involvement of mucus layer, 
tight junction itself in the pathogenesis of UC. 
 
 
Fig. 4. Merged figure (A) of Muc2immunostaining (green, B) and FISH analysis using the 
general bacterial probe EUB338-Alexa Fluor 555 (red, C) of distal colon, it was shown muc2-
positive goblet cells and the outer mucus layer (Arrow) and inner mucus layer (Star) on the 
epithelium. The inner layer (Star) is devoid of bacteria, which can only be detected in the 
outer mucus layer. The inner mucus generates a spatial separation between the cells and 
microflora. (Scale bar: 20 µm). (D) FISH using the EUB338-Alexa Fluor 555 probe staining 
bacteria and DAPIDNA staining in colon show a clear separation of the bacterial DNA and 
epithelial surface in WT mice, but not in Muc2-/- mice. This separation corresponds to the 
inner mucus layer (s). (Scale bar: 100m). These models adapted from the models presented 
previously (Johansson et al. 2008) 
4.1 Mucus layer 
As mentioned in previous part of this chapter, the digestive tract is home to 1014 bacteria 
and bacteria genome is as many 10 times as human genome, which has evolved to ensure 
homeostasis. How to manage this enormous bacterial load without overt immune responses 
from the adaptive and innate systems is not well understood. When the equilibrium is 
altered, as in the disease ulcerative colitis, inflammatory responses are initiated against the 
commensal bacteria. An important component, often neglected due to lack of 
understanding, is the mucus layer that overlies the entire intestinal epithelium as a 
protective gel-like layer (Johansson et al. 2008). This thick and hyperviscous mucus layer 
secreted by goblet cells overlies the entire intestinal epithelium as a protective gel-like layer 
that can extend up to as much as 150 µm thick in mouse colon (and 800 µm thick in rat 
colon). There exist two different kinds of mucus layer-out layer and inner layer. The 
majority of microorganisms in the lumen can be found in the outer mucus layer, there is an 
inner, protected, and unstirred layer that is directly adjacent to the epithelial surface and is 
relatively sterile. The sterility of this layer contributes to the retention of a high 
concentration of antimicrobial proteins (such as cathelicidiens, defensins, and cryptidens) 
Merge Muc2 staining Bacterial fish
A B C D E
WT Muc2 -/-
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produced by various intestinal epithelial lineages, including enterocytes and Paneth cells. 
The inner firmly attached mucus layer forms a specialized physical barrier that excludes the 
resident bacteria from a direct contact with the underlining epithelium. This organization of 
the colon mucus, as based on the properties of the Muc2 mucin, should be ideal for 
excluding bacteria from contacting the epithelial cells and thus also the immune system. 
Alterations or the absence of these protective layers, as in the Muc2-/- mouse colon, allow 
bacteria to have a direct contact with epithelial cells, to penetrate lower into the crypts and 
also translocate into epithelial cells. That such a close contact between bacteria and epithelia 
can trigger an inflammatory response (Johansson et al. 2008; Shen et al. 2009). The surface 
mucus layer also impacts mucosal permeability, as demonstrated by spontaneous colitis in 
Muc-2- deficient mice (Bergstrom et al. 2010), and increased DSS-induced colitis in intestinal 
trefoil factor deficient mice (Mashimo et al. 1996) and in human UC. The importance of the 
Muc2 mucin in organizing the colon mucus protection is further strengthen by the report 
that two mouse strains with diarrhea and colon inflammation were shown to have two 
separate spontaneous mutations in the Muc2 mucin (Heazlewood et al. 2008). Importantly, 
the production of mucin is regulated by protein kinases, for example, resistin and resistin-
like molecule (RELM) beta upregulated mucin expression which dependent on the kinase 
activities of protein kinase C (PKC), tyrosine kinases, and extracellular-regulated protein 
kinase (Krimi et al. 2008); Cathelicidin stimulates colonic mucus synthesis by up-regulating 
MUC1 and MUC2 expression through a mitogen-activated protein kinase pathway (Tai et 
al. 2008). 
4.2 Epithelial cell and its tight junction 
The cellular components of the intestinal barrier consist of the complete array of columnar 
epithelial cell types (enterocyte, paneth cells, enteroendorine cells, and goblet cells) present 
within the intestine. These cells are polarized with an apical membrane and a basolateral 
membrane, and apical membrane composition is distinct from the basolateral membrane, for 
example, the nutrient transporters are located on the apical membrane; they use Na+ ions 
cotransport to provide the energy and directionality of transport. In contrast, the Na+K+-
ATPase, which establishes the Na+ electrochemical gradient, is present on basolateral, but 
not apical membranes. In addition, the lipid composition of the membrane differs; the apical 
membrane is enriched in sphingolipids and cholesterol relative to the basolateral membrane. 
One result of this cellular polarization is that the apical membranes of intestinal epithelial 
cells are generally impermeable to hydrophilic solutes in the absence of specific 
transporters. Thus, the presence of epithelial cells, particularly the apical membranes, 
contributes significantly to the mucosal barrier (Shen et al. 2009). Among the most important 
structures of the intestinal barrier are the epithelial tight junctions (TJs) that connect adjacent 
enterocytes together to determine paracellular permeability. The tight junction is composed 
of multiple proteins including transmembrane proteins such as occludin, tricellulin, 
claudins and junctional adhesion molecule (JAM). The intracellular portions of these 
transmembrane proteins interact with cytoplasmic peripheral membrane proteins, including 
zona occludens (ZO)-1,-2,-3 and cingulin (Mitic & Anderson. 1998). These tight junction and 
cytoplasmic proteins then interact with F-actin and myosin II, thereby anchoring the tight 
junction complex to the cytoskeleton. Once thought to be static, the association of these 
proteins with the tight junction is highly dynamic (Shen et al. 2009) and may play a role in 
epithelial barrier regulation. Occludin was the first tight junction-associated integral 
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membrane protein identified (Furuse et al. 1993). Although occludin knockout mice exhibit 
intact intestinal epithelial tight junctions and display no observable barrier defect (Schulzke 
et al. 2005, Saitou et al. 2000). But in vitro studies demonstrate crucial roles in tight junction 
assembly and maintenance (Yu et al. 2005; Suzuki et al. 2009; Elias et al. 2009). This suggests 
that further analysis of occludin knockout mice under stressed condition may reveal in vivo 
functions of occludin and provide new insight into mechanisms of tight regulation (Turner 
2006). Given the phylogenetic and structural similarities between occludin and tricellulin 
(Ikenouchi et al. 2005), it may be that the tricellulin accounts for normal intestinal barrier 
function in occludin knockout mice. This hypothesis could also be applied to inflammatory 
bowel disease, where intestinal epithelial occludin expression is reduced (Heller et al. 2005). 
The fact that occludin knockout mice exhibit intact intestinal epithelial barrier function led 
to the search for additional tight junctional components and ultimately to the discovery of 
the claudins (Furuse et al. 1998). The claudins are a large family of proteins that also interact 
with partners on neighboring cells to affect junctional adhesions via extracellular loops. At 
least 24 different claudin proteins are present in mammals (Van Itallie et al. 2003, 2004, 
2006), and these proteins are the primary component of tight junction strands (Furuse et al. 
2006). Claudins are expressed in a tissue-specific manner, studies on human intestine 
confirm the expression of claudins-1, -2, -3, -4, -5, -7, and -8 in the colon, expression of 
claudins-1, -2, -3, and -4 in the duodenum, and expression of claudins-2 and -4 in the 
jejunum (Burgel et al 2002;  Escaffit et al 2005, Szakal et al. 2010; Wang et al. 2010; Zeissing et 
al. 2007).  
The molecular anatomy of transport through tight junction is not yet clear, at least two 
routes allow transport across the tight junction, and the relative contributions of different 
paracellular transport are regulated independently (Fihn et al. 2000; Van Itallie 2008; Watson  
et al. 2005). One route, the size-dependent pathway, allows paracellular transport of large 
solutes, including limited flux of proteins and bacterial lipopolysaccharides (Van Itallie 
2008; Watson et al. 2005). Although at what size particles are excluded from the leak 
pathway has not been precisely defined, it is clear that materials as large as whole bacteria 
cannot pass. Flux across the leak pathway may be increased by cytokines and protein 
kinases, including IFNǄ, TNF (Watson et al. 2005; Wang et al. 2005; Clayburgh et al. 2006), 
MAPKs, myosin II light chain kinase (MLCK) (Turner 2006) and SPAK (Yan 2011). A second 
pathway is charge-dependent pathway, characterized by small pores that are defined by 
tight junction-associated pore-forming claudin proteins (Amasheh et al. 2002; Colegio et al. 
2003; Simon et al. 1999). These pores have a radius that excludes molecules larger than 4 A 
(Van Itallie 2008; Watson et al.2005). Thus, tight junctions show both size selectivity and 
charge selectivity, and these properties may be regulated individually or jointly by 
physiological or pathophysiological stimuli. It need to point out that barrier dysfunction 
may be caused by increased paracellular permeability, but mainly by epithelial damage, 
including erosion, and ulceration (Zeissig et al. 2004; Schulzke et al.2006). In addition, in 
epithelial cells, the site of claudin protein polymerization to form strands depends on ZO 
family protein expression (Furuse & Tsukita 2006), and cells lacking ZO-1 and ZO-2 fail to 
form tight junctions at all.  
Generally, TJ proteins can be subdivided into ‘‘tightening’’ TJ proteins that strengthen 
epithelial barrier properties (such as occluding and claudin-1 and -4 etc) and ‘‘leaky’’ TJ 
proteins (like claudin-2) that selectively mediate paracellular permeability. Dysfunctional 
intestinal barrier is a feature of gut inflammation in humans and has been implicated as a 
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pathogenic factor in IBD for the last 30 years. The factors responsible for barrier dysfunction 
in UC are similar to those in CD, including an increase in epithelial antigen transcytosis and 
a change in TJ structure with a reduction in TJ strand count and in the depth of the TJ main 
meshwork; although, in contrast to CD, strand breaks are not as frequent as in UC (Schmitz 
et al. 1999; Schurmann et al. 1999). Again, the downregulation of occludin and 
downregulation of several ‘‘tightening’’ TJ proteins like claudin-1 and -4, together with an 
upregulation of the pore-forming TJ protein claudin-2 contribute to the barrier defect 
observed in UC (Heller et al.2005; Oshima et al. 2008). These disruptions of tight junction 
proteins could lead to a breakdown in the protective barrier and can be used as a portal of 
entry by the luminal bacteria. This breach in intestinal barrier can result in inflammatory 
infiltrate and enhanced production of cytokines and other mediators (such as neutrophil) 
that can further contribute to the altered barrier function.  
 
 
Fig. 5. Molecular composition of tight junctions. This model adapted from the model 
presented previously: 
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2413111/?tool=pubmed 
Mucosal permeability is influenced by several factors. The surface mucus layer also impacts 
mucosal permeability, as demonstrated by spontaneous colitis in Muc-2- deficient mice (Van 
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der Sluis et al. 2006), and increased DSS-induced colitis in intestinal trefoil factordeficient 
mice (Mashimo et al. 1996). Luminal microbiota can also compromise the intestinal barrier 
function (Packey & Sartor, 2008). The third is the integrity of the epithelial cell layer and the 
basement membrane. Molecularly this can be compromised by downregulating tight 
junction components Claudins 5 and 6, upregulating pore-forming Claudin 2 (Zessig et al. 
2007 ), which can be accomplished by TNF and IL-13, or increasing epithelial apoptosis, 
which has been achieved in mice by blocking nuclear factor kappa-B (NFκB) signalling. 
Genetic factors are involved in the loss of intestinal barrier function (Cho & Brant 2011). 
Dysregulated innate and adaptive immune system can lead to the enhanced epithelial 
permeability (Fuss 2008). Finally, autonomic nerve system function affects epithelial 
permeability, as demonstrated by mice that develop fulminant jejunoileitis following 
ablation of enteric glial cells (Bush et al. 1998). 
 
 
Fig. 6. Binding of microbial adjuvants to extracellular and intracellular pattern-recognition 
receptors and initiate their function by activating protein kinases. Toll-like receptors on the 
cell membrane selectively bind to various bacterial, viral or fungal components. This ligation 
activates conserved signaling pathways that activate NFĸB and mitogen-activated protein 
kinases. These transcription factors stimulate the expression of a number of 
proinflammatory and antiinflammatory genes. This model adapted and modified from the 
model presented previously. 
http://www.nature.com/nrgastro/journal/v3/n7/full/ncpgasthep0528.html 
The increased uptake of antigens and macromolecules from the intestinal lumen mediated 
through this epithelial barrier dysfunction can further exacerbate the inflammatory process, 
ending up in a vicious circle. In this manner, barrier dysfunction is a perpetuating principle 
during gastrointestinal inflammation. Since epithelial TJs are important in the maintenance 
of barrier function, regulatory changes in their function that are commonly found during 
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intestinal inflammation can have severe consequences. For example, the resulting passive 
loss of solutes into the intestinal lumen and the subsequent osmotically driven water flow 
results in ‘‘leak flux diarrhea’’, one of the main consequences of UC. The tight junction is, 
therefore, the rate-limiting step in transepithelial transport and the principal determinant of 
mucosal permeability. But it has to be pointed out that barrier dysfunction itself is not 
sufficient to cause intestinal diseases, such as in MLCK (Turner 2006) and SPAK (Yan 2011) 
transgenic mice, these two different transgenic mice revealed increased transepithelial 
permeability, but neither of them demonstrated any UC characterization, for example, these 
mice develop normal, no significant weight loss, histologically normal crypts were found, 
no abscesses was noticed.  
Recent molecular advances as well as studies of cellular physiology in model epithelia have 
instead revealed that both the permeability and selectivity of tight junctions can be 
modulated dynamically by a variety of signals (Mitic et al., 2000). Much of the progress in 
this field has rested on a significantly enhanced understanding of the proteins that make up 
the junction itself, as well as those components of the junction on its cytoplasmic face that 
link the junctional region both to the cellular cytoskeleton and to signal transduction 
modules (González-Mariscal et al. 2003).  
5. Protein kinase and pathogenesis of UC 
5.1 Mitogen activated protein kinases (MAPK) 
Interestingly, protein kinases are associated with all different level of aspects, demonstrated 
promising potential as intervention targets against UC. Intracellular signaling cascades are 
the main route of communication between the plasma membrane and regulatory targets in 
various intracellular compartments. The evolutionarily conserved mitogen activated protein 
kinases (MAPK) signaling pathway plays an important role in transducing signals from 
diverse extra-cellular stimuli (including growth factors, cytokines and environmental 
stresses) to the nucleus in order to affect a wide range of cellular processes, such as 
proliferation, differentiation, development, stress responses and apoptosis. MAPK (Coskun 
et al,2011) signaling cascades, which comprise up to seven levels of protein kinases, are 
sequentially activated by phosphorylation and also involved in intestinal inflammation. 
These families can be divided into two groups: the classical MAPKs, consisting of ERK1/2, 
p38, JNK and ERK5, and the atypical MAPKs, consisting of ERK3, ERK4, ERK7 and NLK 
(Coulombe & Meloche, 2007). The signalling pathways which the members of these families 
influence can be independent of each other or overlapping. The classical pathway leading to 
activation of ERK1/2 is through the upstream activation of the Raf MAPKKKs, which 
activate sequentially the MAPKKs, MEK1/2, which can specifically bind and phosphorylate 
ERK1/2. At this stage, and depending upon the signal being propagated, the ERK1/2 
proteins commonly then phosphorylate the downstream MAPK activated proteins 
(MAPKAP) 1/2. However, other proinflammatory proteins such as cytosolic phospholipase 
A2 can be activated, as well as several transcription factors including Ets-1, Elk and c-myc. 
These transcription factors aid the inflammatory process by inducing other related cellular 
processes such as cell migration and proliferation. Interestingly, a role for ERK1/2, using an 
ERK1/2 inhibitor, was found in cells of the immune system and colonocytes in the 
development and progression of IBD, through its mediation in the signalling pathways 
induced by various cytokines, for example IL-21, and IL-1 (Caruso et al.2007; Kwon et 
www.intechopen.com
 Protein Kinases and Ulcerative Colitis 
 
63 
al.2007). Indeed, several studies, cell line cultures and isolated crypts from human biopsies, 
have shown that it is not only over-expressed in IBD tissue (both colonocytes and cells in the 
underlying lamina propria), but that its phosphorylation state and therefore activation state 
is increased significantly during the active stages of IBD (Waetzig et al.2002; Dahan et 
al.2008). Study also found that Erk activation is involved in claudin-4 protein expression and 
claudin-4 is involved in the maintenance of the intestinal epithelial cell barrier function 
(Pinton et al. 2010) as a “tightening” junction protein. Activation of p38/MAPK and Akt 
signal transduction pathways in the epithelial cells have also been implicated as key 
mediators of these protective effects (Resta-Lenert and Barrett. 2006). For example, 
Lactobacillus GG (LGG) prevents cytokine-induced apoptosis in both human and mouse 
intestinal epithelial cells through activating antiapoptotic Akt in a phosphatidylinositol-3-
kinase (PI3K)-dependent manner and inhibiting proapoptotic p38/MAPK activation (Yan 
and Polk. 2002). The p38 family is composed of four members: ǂ, ǃ, Ǆ and ǅ. Expression of 
the isoforms varies between tissues. Different ligands, via their respective receptors, are able 
to activate one or several of p38 targets TAK1, ASK1, MLK3, MEKK1-4 and TAO1-3 
(Thalhamer et al.2008). Several studies using the p38 inhibitor, SB203580, have indicated that 
p38 phosphorylation is increased significantly in IBD tissue (Waetzig et al.2002; Dahan et 
al.2008). This finding is substantiated further by an in vitro study, indicating that inhibition 
of p38 using the natural IL-1 receptor antagonist, in a colonocyte cell line, leads to reduced 
IL-6 and -8 production, and an in vivo study using a murine model of IBD, where inhibition 
of p38 reduced significantly cytokine mRNA and NFκB activation (Garat et al.2003; 
Hollenbach et al.2004). However, Heat-killed L. brevis SBC8803 induced Hsps, 
phosphorylated p38 MAPK, regulated the expression of tumor necrosis factor alpha (TNF-
ǂ), interleukin (IL)-1ǃ and IL-12, and improved the barrier function of intestinal epithelia 
under oxidant stress (Ueno et al. 2011). 
There are three JNK isoforms, JNK1, 2 and 3, of which there are 10 splice forms in total. 
Studies using a specific inhibitor against JNK1/2 in induced IBD in rodent models or with 
isolated colonic tissue found that proinflammatory cytokine production was reduced in 
conjunction with reduced inflammatory cell infiltration. Similarly, increased 
phosphorylation of JNK1/2 was seen in inflamed tissue from IBD patients (Dahan et al.2008; 
Assi K et al.2006; Mitsuyama et al.2008). RDP58 (Loftberg et al.2002) is a peptide consisting 
of 9 D-amino acids blocking p38 and JNK, further attenuate UC. 
5.2 Serine and threonine kinase 
5.2.1 Ste20 related proline/alanine rich kinase (SPAK) 
SPAK is defined as a ste20-like proline-/alanine rich kinase that contains an N-terminal 
series of proline and alanine repeats (PAPA box) followed by a kinase domain, a nuclear 
localization signal, a consensus caspase cleavage motif, and a C-terminal regulatory region 
(Johnston et al.2000). Colonic SPAK exists as a unique isoform that lacks the PAPA box and 
F-ǂ helix loop in the N-terminus (Yan et al.2007). The diversity of domains present in SPAK 
protein might be associated with a variety of biological roles. For example, SPAK has been 
shown to play roles in cell differentiation, cell transformation and proliferation, and 
regulation of chloride transport (Piechotta et al.2002; Gagnon et al.2006). More importantly, 
a linkage has been established between SPAK and inflammation, SPAK, as an upstream 
kinase to Na+-K+-2Cl− co-transporter 1 (NKCC1), can phosphorylate Thr203, Thr207, and 
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Thr212 amino acids on NKCC1, which play an important role in inflammation (Topper et 
al.1997). Furthermore, we have demonstrated that SPAK can activate p38 pathway (Yan et 
al. 2007) that is well known involving inflammation. SPAK caused an increase in intestinal 
permeability, and SPAK transgenic (TG) mice were more susceptible to experimental colitis. 
Additionally, increased cytokine production and bacterial translocation were associated 
with the increased colitis susceptibility (Yan Y et al 2011). 
5.2.2 Myosin II light chain kinase (MLCK) 
MLCK is a specific Serine and threonine kinase which can phosphorylate MLC. It has been 
found that MLCK activity is required for TNF-induced acute diarrhea. Further, TNF 
treatment resulted in increased myosin light chain kinase expression (Wang et al. 2005), as a 
result of transcriptional activation (Graham et al. 2006) in vitro and in vivo. Constitutive 
MLCK activation accelerates onset and increases severity of experimental UC. MLCK 
inhibition, either pharmacologically or by genetic knockout, prevented both intestinal 
epithelial MLC phosphorylation and barrier dysfunction. More remarkably, MLCK 
inhibition also restored net water absorption, and therefore corrected the TNF-dependent 
diarrhea (Clayburgh DR). 
6. Conclusions 
Protein kinase have been implicated in the pathogenesis of a variety of human disorders 
including UC, continuing progress in the understanding of the roles of protein kinases in 
intestinal barrier dysfunction, further in IBD pathogeneses offers hope for a new 
generation of therapeutic strategies targeted at the modulation of protein kinase activity. 
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